Featured Research

from universities, journals, and other organizations

Scientists Link Vascular Gene To Alzheimer's Disease

Date:
August 15, 2005
Source:
University of Rochester Medical Center
Summary:
Scientists have discovered a link between a prominent developmental gene and neurovascular dysfunction in Alzheimer's disease. The gene plays a major role in the growth and remodeling of vascular systems. But, in brain cells of people with Alzheimer's disease, expression of the gene is low, the scientists found, revealing a new piece of the Alzheimer's puzzle.

Scientists at the University of Rochester Medical Center have discovered a link between a prominent developmental gene and neurovascular dysfunction in Alzheimer's disease.

The gene plays a major role in the growth and remodeling of vascular systems. But, in brain cells of people with Alzheimer's disease, expression of the gene is low, the scientists found, revealing a new piece of the Alzheimer's puzzle.

In laboratory studies, the scientists also showed that restoration of the gene expression level in the human brain cells stimulated the formation of new blood vessels. It also increased the level of a protein that removes amyloid beta peptide, the toxin that builds up in brain tissue in Alzheimer's disease.

In further studies, the scientists, led by Berislav Zlokovic, M.D., Ph.D., deleted one copy of the gene in mice, creating echoes of the damage of Alzheimer's, including reduced ability to grow blood vessels in the brain and impaired clearance of amyloid beta.

"This is a new pathway for the study and treatment of Alzheimer's disease," said Zlokovic. "This gene could be a therapeutic target. If we can stop this cycle, we could slow or stop the progression of the neuronal component of this disease."

An article by Zlokovic and his team detailing the research findings appears Sunday Aug. 14 in the online version of Nature Medicine. The article will be published in the September print edition of Nature Medicine.

Zlokovic is a professor in the University of Rochester Medical Center's Department of Neurosurgery and director of the Frank P. Smith Laboratories for Neuroscience and Neurosurgical Research.

The gene targeted in the research is a homeobox gene known as MEOX2 and also as GAX. A homeobox gene encodes proteins that determine development. Zlokovic calls it a "big boss."

The scientists studied human brain endothelial cells taken from autopsy samples from people with Alzheimer's. They found that expression of MEOX2, or mesenchyme homeobox 2, is low in the cells of those with Alzheimer's.

"The cells with low levels can't form any kind of vascular system or any kind of network," Zlokovic said. "They just start dying."

In restoring expression of the gene, the Rochester scientists showed for the first time that it suppresses a specific transcription factor. When the expression of MEOX2 is low, the factor "rampages" and allows apoptosis or programmed cell death in the brain vascular system, Zlokovic said.

When MEOX2 expression is low, the research also showed that a protein that helps with the clearance of amyloid beta is suppressed.

Zlokovic views the findings reported in Nature Medicine as support for his belief that Alzheimer's is a neurovascular disease.

"If you find a problem in the brain, it doesn't necessarily mean that it started in the brain," he said. "It's not that neuronal injury is not important. It's that other things are more important."

But Zlokovic said that it is not clear yet whether the low expression of the gene results in the death of brain cells and Alzheimer's disease or that the disease in neurons results in the low expression of the disease.

"But if we can restore the dysfunctional gene, we might be able to slow or stop the disease wherever it started," Zlokovic said.

###

The National Institutes of Health provided some of the funding for the research.

In November 2004, Zlokovic received a MERIT award from the National Institute on Aging. The award, worth approximately $5 million in funding, will be used to further his research for new ways to treat or prevent Alzheimer's disease. Zlokovic was selected by his peers at NIH to receive the award based on the consistent high quality of his work and leadership and commitment in the field over several years.


Story Source:

The above story is based on materials provided by University of Rochester Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Rochester Medical Center. "Scientists Link Vascular Gene To Alzheimer's Disease." ScienceDaily. ScienceDaily, 15 August 2005. <www.sciencedaily.com/releases/2005/08/050814161908.htm>.
University of Rochester Medical Center. (2005, August 15). Scientists Link Vascular Gene To Alzheimer's Disease. ScienceDaily. Retrieved April 16, 2014 from www.sciencedaily.com/releases/2005/08/050814161908.htm
University of Rochester Medical Center. "Scientists Link Vascular Gene To Alzheimer's Disease." ScienceDaily. www.sciencedaily.com/releases/2005/08/050814161908.htm (accessed April 16, 2014).

Share This



More Health & Medicine News

Wednesday, April 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Now Linked To 121 Deaths

Ebola Outbreak Now Linked To 121 Deaths

Newsy (Apr. 15, 2014) The ebola virus outbreak in West Africa is now linked to 121 deaths. Health officials fear the virus will continue to spread in urban areas. Video provided by Newsy
Powered by NewsLook.com
Cognitive Function: Is It All Downhill From Age 24?

Cognitive Function: Is It All Downhill From Age 24?

Newsy (Apr. 15, 2014) A new study out of Canada says cognitive motor performance begins deteriorating around age 24. Video provided by Newsy
Powered by NewsLook.com
How Mt. Everest Helped Scientists Research Diabetes

How Mt. Everest Helped Scientists Research Diabetes

Newsy (Apr. 15, 2014) British researchers were able to use Mount Everest's low altitudes to study insulin resistance. They hope to find ways to treat diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins